317 related articles for article (PubMed ID: 32556562)
21. Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion.
Tagami Y; Sugita S; Kubo T; Iesato N; Emori M; Takada K; Tsujiwaki M; Segawa K; Sugawara T; Kikuchi T; Hasegawa T
Pathol Res Pract; 2019 Aug; 215(8):152399. PubMed ID: 30948206
[TBL] [Abstract][Full Text] [Related]
22. Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
El Zein S; Djeroudi L; Reynaud S; Guillemot D; Masliah-Planchon J; Frouin E; Nicolas N; Le Loarer F; Daniel C; Delattre O; Pierron G; Watson S
Genes Chromosomes Cancer; 2022 Apr; 61(4):200-205. PubMed ID: 34877752
[TBL] [Abstract][Full Text] [Related]
23. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
[TBL] [Abstract][Full Text] [Related]
24. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
[TBL] [Abstract][Full Text] [Related]
25. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
[TBL] [Abstract][Full Text] [Related]
26. Mandibular rhabdomyosarcoma with TFCP2 rearrangement and osteogenic differentiation: a case misdiagnosed as fibrous dysplasia or low-grade central osteosarcoma.
Chen F; Wang J; Sun Y; Zhang J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jun; 137(6):e143-e149. PubMed ID: 38637236
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y
Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070
[TBL] [Abstract][Full Text] [Related]
28. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract][Full Text] [Related]
29. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
30. Intra-Abdominal Epithelioid Neoplasm With EWSR1::CREB Fusions Involving the Kidney: A Clinicopathologic and Molecular Characterization With an Emphasis on Differential Diagnosis.
Zhao M; Gan H; Zhong S; Xia Q; Bai Y; Xu J; Teng X; Wang J
Mod Pathol; 2024 May; 37(5):100468. PubMed ID: 38460673
[TBL] [Abstract][Full Text] [Related]
31. EWSR1/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities.
Argani P; Harvey I; Nielsen GP; Takano A; Suurmeijer AJH; Voltaggio L; Zhang L; Sung YS; Stenzinger A; Mechtersheimer G; Dickson BC; Antonescu CR
Mod Pathol; 2020 Nov; 33(11):2233-2243. PubMed ID: 32770123
[TBL] [Abstract][Full Text] [Related]
32. Epithelioid and Spindle Cell Rhabdomyosarcoma of the Oral Mucosa with FUS Rearrangement.
Ochsner AR; Foss RD
Head Neck Pathol; 2022 Sep; 16(3):823-827. PubMed ID: 35353344
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.
Shibayama T; Shimoi T; Mori T; Noguchi E; Honma Y; Hijioka S; Yoshida M; Ogawa C; Yonemori K; Yatabe Y; Yoshida A
Am J Surg Pathol; 2022 Jan; 46(1):134-146. PubMed ID: 34049318
[TBL] [Abstract][Full Text] [Related]
34. The current landscape of rhabdomyosarcomas: an update.
Leiner J; Le Loarer F
Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
[TBL] [Abstract][Full Text] [Related]
35. A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.
Dashti NK; Dickson BC; Zhang L; Xie Z; Nielsen GP; Antonescu CR
Genes Chromosomes Cancer; 2021 Nov; 60(11):762-771. PubMed ID: 34310785
[TBL] [Abstract][Full Text] [Related]
36. Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones.
Silva Cunha JL; Cavalcante IL; da Silva Barros CC; Alves PM; Nonaka CFW; Albuquerque AFM; de Almeida OP; de Andrade BAB; Cavalcante RB
Oral Oncol; 2022 Jul; 130():105876. PubMed ID: 35550988
[TBL] [Abstract][Full Text] [Related]
37. Intraosseous Spindle Cell Rhabdomyosarcoma with
Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
[TBL] [Abstract][Full Text] [Related]
38. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
39. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
